Fillers as an adjuvement treatment for facial dysmorphism
REPORT summary
Patient
A 23-year-old male with severe maxillomandibular discrepancy and indication for double jaw surgery presented with poor bone support in the midface and mandibular angles.
Results
The filler provided strong projection, enhancing facial symmetry and contour. As a minimally invasive alternative to bone grafts or PSI, Neauvia Intense offers durable results (15–24 months).
Treatments
To complement surgical correction, PEGHA filler (Neauvia Intense Flux, 28 mg/ml) was injected: midface (3 boluses/side, 1.5 ml), mandibular angle (0.7 ml bolus), and jawline (1 ml cannula).
PRODUCTS used
discover more
CLINICAL CASES
want to know more about
our treatments?
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently based on numerous factors. Outcomes are variable and not guaranteed.